These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 30787269)

  • 21. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
    Zheng T; Zhang Z
    Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
    Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
    Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
    Stoll AC; Kemp CJ; Patterson JR; Howe JW; Steece-Collier K; Luk KC; Sortwell CE; Benskey MJ
    Neurobiol Dis; 2024 Feb; 191():106411. PubMed ID: 38228253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease.
    Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H
    J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
    Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
    Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
    Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
    Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
    Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
    Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
    Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
    Niu H; Wang Q; Zhao W; Liu J; Wang D; Muhammad B; Liu X; Quan N; Zhang H; Zhang F; Wang Y; Li H; Yang R
    Brain Pathol; 2020 Nov; 30(6):1102-1118. PubMed ID: 32678959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.
    Zou J; Guo Y; Wei L; Yu F; Yu B; Xu A
    Neurotherapeutics; 2020 Jul; 17(3):1104-1119. PubMed ID: 32236821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
    Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E
    Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATP13A2/PARK9 regulates secretion of exosomes and α-synuclein.
    Tsunemi T; Hamada K; Krainc D
    J Neurosci; 2014 Nov; 34(46):15281-7. PubMed ID: 25392495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice.
    Huang Y; Liu Z; Li N; Tian C; Yang H; Huo Y; Li Y; Zhang J; Yu Z
    Ann Neurol; 2022 Aug; 92(2):230-245. PubMed ID: 35596947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression.
    Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA
    Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.
    Chistiakov DA; Chistiakov AA
    Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes.
    Bliederhaeuser C; Grozdanov V; Speidel A; Zondler L; Ruf WP; Bayer H; Kiechle M; Feiler MS; Freischmidt A; Brenner D; Witting A; Hengerer B; Fändrich M; Ludolph AC; Weishaupt JH; Gillardon F; Danzer KM
    Acta Neuropathol; 2016 Mar; 131(3):379-91. PubMed ID: 26576561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increases in miR-124-3p in Microglial Exosomes Confer Neuroprotective Effects by Targeting FIP200-Mediated Neuronal Autophagy Following Traumatic Brain Injury.
    Li D; Huang S; Yin Z; Zhu J; Ge X; Han Z; Tan J; Zhang S; Zhao J; Chen F; Wang H; Lei P
    Neurochem Res; 2019 Aug; 44(8):1903-1923. PubMed ID: 31190315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.